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significance (5.3 days vs. 4.1 days; P = 0.080) and respiratory-related 30-day readmission rates did not differ (9.4% vs. 10.7%; P = 0.801). In addition, treatment failure
defined as ICU admission (3.1% vs. 0%; P = 0.210), requirement for invasive mechanical ventilation (3.1% vs. 0%; P = 0.210), and death (1.6% vs. 0%; P = 0.460) did not
differ significantly between groups.
Conclusion. Implementation of a PCT-guided protocol for the treatment of
COPD exacerbations was associated with a significant reduction in antimicrobial days
of therapy. We noted a trend in decreasing LOS and no difference respiratory-related
30-day readmissions, or treatment failure. Our PCT-guided protocol has been demonstrated to safely reduce antibiotic utilization in patients with COPD exacerbations.
Disclosures. All authors: No reported disclosures.
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Background. Current guidelines provide vague recommendations regarding
antibiotic choice, duration and patients most likely to benefit from antibiotics during an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We
sought to improve antibiotic prescribing through multidisciplinary creation of a clinical guidance document, order set with imbedded clinical decision support (CDS), and
provider education on the management of AECOPD.
Methods. A quasi-experimental study was conducted in adult patients (age
>18 years) admitted to Nebraska Medicine for suspected AECOPD before and after
clinical decision support was introduced. Patients in the pre-implementation period
(10 weeks, April 2015–June 30, 2016, N = 44) and a similar post-implementation
period (10 weeks, April 2012–June 29, 2017, N = 51) were included if COPD was the
primary diagnosis code or the COPD exacerbation order set was used at admission.
Exclusion criteria included AECOPD admission within the previous 30 days and
transfer from an outside hospital. Outcome measures included: percentage of patients
receiving antibiotics, median length of therapy, order set usage, antibiotic choices,
length of stay (LOS) and oral steroid use.
Results. Post-implementation, the percentage of patients prescribed antibiotics
decreased (86.4% vs. 60.8%, P = 0.006) as did antibiotics ordered from the order set
(29.5% vs. 13.7%). Median length of therapy decreased from 5 days to 1 day pre- vs.
post-implementation, respectively. Fluoroquinolone use decreased from 43.2 to 25.5%
while azithromycin use remained consistent (18.2% vs. 17.6%). Oral steroid use
increased post-implementation (27.3% vs. 41.2%) and average duration of steroid use
decreased (11.1 vs. 8.7 days). Average LOS was 3.7 days in both groups and in-hospital
mortality was low (2% vs. 0%).
Conclusion. Implementation of an AECOPD guidance document, order set with
CDS, and education resulted in significant decreases in antibiotic usage, particularly
for fluoroquinolones. Other areas of care also improved using a syndromic stewardship
strategy. Our data supports the utilization of this strategy to promote evidence-based
antibiotic management in AECOPD.
Disclosures. All authors: No reported disclosures.
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Background. Despite a growing interest in emerging pathogens in CF, research
has largely overlooked commonplace organisms. Escherichia coli has been reported in
up to 50% of CF respiratory samples, yet little is known about its clinical impact. We
sought to investigate outcomes of E. coli infection in CF.
Methods. We undertook a retrospective cohort study of patients (≥18 years)
attending a Canadian CF clinic between 1978 and 2016 with at least one E. coli positive sputum culture. Infection was classified as transient (≥1 isolate) or persistent (≥3
isolates over a period ≥6 months). Clinical and demographic data were collected from
patient charts 2 years pre- and post-incident infection. For each patient with persistent infection, we collected data on two age (±3 years), sex, and time-matched control
patients for comparison. Outcomes sought included risk of pulmonary exacerbation
(PEx), lung function decline (FEV1), antibiotic days, and progression to transplant or
death. Susceptibility testing was performed as per CLSI standards.
Results. A total of 45 (12.3%) patients (median age 23.5 (IQR 20.0–34.8), 52%
male) cultured E. coli in their sputum at least once. At incident infection, 24% had PEx
but this was not increased relative to prior visits (RR 0.9, P = 1.00). Of the cohort, 18
(40%) developed persistent infection. Persistent infection developed in patients with
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Background. HIV–TB coinfection leads to a complex set of synergistic interactions
in the epidemiology, risk of acquisition, pathogenesis and prognosis of both infections.
In the United States, the prevalence of HIV-TB coinfection has been around 6% for the
past several years. We present here a 5-year experience at a public health department
ambulatory care setting in Tampa, Florida, showing potentially changing patterns.
Descriptive data and clinical aspect of coinfected patients is presented.
Methods. A retrospective review of tuberculosis cases over the 5-year period ending December 2017 was performed. Those with HIV coinfection were included in the
study. Clinical, microbiological and/or PCR based testing methods were used to make
the diagnosis. SPSS was used to compile basic descriptive statistics
Results. There were a total of 411 TB patients and 33 had HIV, an 8% prevalence
of coinfection. The median age was 45 years (range 18–65). The male to female ratio
was 21:12. Twenty-four percent (8/33) were homeless and 24% were foreign born. Only
one patient admitted to using injection drugs while 27% (9/33) used non-injection
illicit drugs. Forty-five percent (15/33) had TB symptoms such as fever, night sweats,
weight loss and cough; the rest had radiographic abnormality which led to the diagnosis. Only 12% (4/33) had CT scan abnormality reported as cavitary or miliary while
the rest had nonspecific infiltrates. Eighty-eight percent (29/33) had pulmonary TB
while 6% had lymph node and 6% serosal (one pleural and one peritoneal) infections.
Seventy-nine percent (29/33) were treated with a combination of daily observed and
self-administered therapy. Twelve percent (4/33) did not complete therapy, or were lost
to follow-up whereas one person was diagnosed post mortem thus not treated.
Conclusion. The prevalence of HIV-TB coinfection in our cohort is slightly
higher than the recent US average of 6% perhaps signifying the setting and demographics of our patient population. Our cohort was relatively older, most of them US
born, and had predominantly pulmonary TB contrary to prior reports. These changing
patterns may have been influenced by the overall older age of HIV patients in general
or they could be indicators of underlying fundamental changes in the HIV-TB coinfection state at large. Additional study is needed to further elucidate this variance.
Disclosures. All authors: No reported disclosures.
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Background. S. maltophilia is an environmental multi-drug-resistant Gramnegative bacteria that is mostly found as a respiratory tract colonizer in patients with
cystic fibrosis (CF) and as an opportunist in immunocompromised hosts. To understand the role of this pathogen in non-CF patients, we performed a retrospective
analysis of hospitalized patients with S. maltophilia empyema in the Veterans Health
Administration (VHA).
Methods. Using microbiology results within the VHA Corporate Data
Warehouse, we identified pleural fluid cultures that tested positive for S. maltophilia
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lower nutritional scores (BMI) (−2.6 kg/m2, P < 0.001) and lung function (FEV1%;
57.2 vs. 74.2, P = 0.02). Compared with matched controls, those with persistent infection had no increase in mean annual lung function decline (difference −1.06%/year,
P = 0.24), odds of PEx (OR 1.4, P = 0.26), or mean annual hospital IV days (difference:
0.31 days, 95% CI −4.97 to 5.59 days, P = 0.91). Five patients underwent lung transplantation and three died at 5-year follow-up, but this did not differ between transient
and persistent infection (P = 0.63 and P = 0.25, respectively). TMP-SMX resistance
(P = 0.05), but not ESBL production in incident isolates, was predictive of persistence
(P = 0.56).
Conclusion. In this Canadian CF cohort, E. coli infection was common and
occurred more frequently in patients with compromised nutrition and lung function.
Persistent infection with E. coli did not portend worse clinical outcomes. Multi-centre
studies are merited to further understand the epidemiology and clinical impact of
E. coli infection.
Disclosures. All authors: No reported disclosures.

